A Comprehensive Test for Identifying Functional Nutritional Deficiencies and Insufficiencies

Why Use the NutrEval FMV Profile?

The NutrEval FMV® is both a blood and urine test that evaluates over 125 biomarkers and assesses the body's functional need for 40 antioxidants, vitamins, minerals, essential fatty acids, amino acids, digestive support, and other select nutrients. Personalised recommendations for nutrients are determined by using an algorithm based on the patient's test findings.

Introducing NutrEval® with Genomics

The Nutritional Test You Rely On Just Got Better!

We are excited to announce that we will now be offering select genomics testing (SNPs) on our most complete nutritional profiles: NutrEval FMV amino acids and NutrEval Plasma amino acids.

Assessment of these select genomic markers in conjunction with the NutrEval supports broadened clinical insight and enhanced personalization of therapeutics in an array of patient conditions such as depression, anxiety, cardiovascular disease, cardiometabolic syndrome, inflammatory conditions, and chronic pain syndromes.

NutrEval kit requisitions will now include the option for ordering one or more of the following SNPs:

NutrEval with Genomics
  • COMT
  • TNF-α
  • APOE

When should testing for NutrEval FMV be considered?

According to the World Health Organisation, every country in the world is affected by one or more forms of malnutrition. The term malnutrition addresses 3 broad groups of conditions:1

  • Undernutrition (wasting, stunting, underweight)
  • Micronutrient-related malnutrition from inadequate or excess vitamins or minerals
  • Overweight, obesity, and diet-related noncommunicable diseases (such as heart disease, stroke, diabetes and some cancers)

Proper nutrition is key to preventing a number of diseases. Nutrients are necessary to feed every cell and ensure all body systems are functioning properly. Testing can help clinicians and patients gain an understanding of how nutritional imbalances may be impacting their health. Certain conditions or dietary, genetic, and lifestyle factors may predispose a person to having nutrient imbalances.

Symptoms and conditions associated with nutrient imbalances

  • Mood disorders2-6
  • Cardiovascular disease7,8
  • Obesity/ Insulin resistance/ Type 2 Diabetes9-12
  • Autism13-16
  • Fatigue17-20
  • Weight Issues/ Malnutrition/ Dietary Guidance
  • Maldigestion/Malabsorption
  • Increased nutrient demand in physical trauma/healing21

The NutrEval FMV Biomarkers

The biomarkers on the NutrEval are arranged as follows (see sample report for individual analytes):

  • Metabolic Analysis Markers (urine organic acids)
    • Malabsorption and Bacterial/ Yeast Dysbiosis Markers are metabolites produced by the gastrointestinal microbiome
    • Cellular Energy & Mitochondrial Metabolites are biomarkers of carbohydrate and fatty acid metabolism, and the citric acid (Kreb's) cycle
    • Neurotransmitter Metabolites are downstream byproducts of epinephrine, norepinephrine, serotonin and dopamine
    • Vitamin Marker are specific analytes used to assess functional levels of vitamin cofactors
    • Toxin & Detoxification Markers relate to certain toxic metabolites and the body's detoxification capacity
  • Amino Acids (urine)
    • Essential Amino Acids must be derived from dietary sources
    • Nonessential Amino Acids are synthesised by the body
    • Intermediary Metabolites are byproducts of amino acid metabolism
      • B Vitamin Markers are involved in biochemical reactions that specifically require B vitamins
      • Urea Cycle Markers are byproducts associated with nitrogen detoxification
      • Glycine/Serine Metabolites are involved in the choline to acetylcholine (neurotransmitter) pathway and the methylation pathways
    • Dietary Peptide Related Markers can indicate incomplete protein breakdown

  • Essential and Metabolic Fatty Acids Markers (RBCs)
    • Omega 3 Fatty Acids are essential for brain function and cardiovascular health and are anti-inflammatory
    • Omega 6 Fatty Acids are involved in the balance of inflammation
    • Omega 9 Fatty Acids are important for brain growth, nerve cell myelin, and reducing inflammation
    • Saturated Fatty Acids are involved in liproprotein metabolism and adipose tissue inflammation
    • Monounsaturated Fats include omega 7 fats and unhealthy trans fats
    • Delta-6 Desaturase Activity assesses efficiency of this enzyme to metabolise omega 6's and omega 3's
    • Cardiovascular Risk includes specific ratios and the Omega 3 Index
  • Oxidative Stress Markers include antioxidants glutathione (whole blood) and Coenzyme Q10 (serum), as well as the oxidative damage markers lipid peroxides and 8-OHdG (urine)
  • Vitamin D (serum) measures a total of 25-hydroxyvitamin D3 (cholecalciferol) and 25-hydroxyvitamin D2 (ergocalciferol)
  • Elemental Markers
    • Nutrient Elements are direct measurements of copper and zinc (plasma), magnesium and potassium (RBC), and manganese and selenium (whole blood)
    • Toxic Elements (whole blood) indicate exposure to lead, mercury, arsenic, cadmium or tin within approximately a 90-120 day timeframe
  • Add-on SNPs (buccal swab) include MTHFR, COMT, TNF-a, and APOE

Watch the NutrEval Report Interpretation Now

What advantage does the NutrEval FMV offer compared to other diagnostics?

The NutrEval FMV is one of the most comprehensive nutritional profiles available assessing a broad array of macronutrients and micronutrients, as well as markers that give insight into digestive function, toxic exposure, mitochondrial function, and oxidative stress.

Genova provides a user-friendly report with clinically actionable results including:

  • Suggested digestive support and vitamin, mineral, and fatty acid recommendations based on an algorithmic calculation of functional need for cofactors in the body's metabolism
  • Suggested amino acid recommendations based on patient's direct amino acid measurements
  • Interpretation-At-A-Glance pages provide educational information on nutrient function, causes and complications of deficiencies, and dietary sources

A Functional Nutritional Assessment

There are various methods of assessing nutrient status, including intracellular and extracellular direct measurement, and measuring biochemical pathway markers that require specific nutrient cofactors for proper metabolism. The NutrEval uses a combination of these methods and synthesises the information via an algorithm that determines personalised nutrient needs. The algorithm is based on functional markers shown in the literature to be associated with a need for a particular nutrient.

Functional evaluation of nutritional status assesses metabolic intermediates produced in enzymatic pathways of cellular energy production, detoxification, neurotransmitter breakdown, and amino acid metabolism. Specific metabolites outside of reference range may signal a metabolic inhibition or block. This abnormality may be due to a nutrient deficiency, an inherited enzyme deficit, toxic build-up, or drug effect. It is possible for an individual to have normal blood levels of a vitamin in order to maintain homeostasis, while exhibiting signs of insufficiency/deficiency for that vitamin. For this reason, direct testing of individual nutrients alone does not provide a complete picture.

Other methods of assessing nutrient status, such as intracellular lymphocyte testing, has limited literature support.

Conventional nutritional panels include tests such as complete blood count, comprehensive metabolic panel, iron, ferritin and other select nutrients. The NutrEval is not meant to be a substitute for this important testing, but rather a complement by providing additional information.

What can clinicians and patients expect from NutrEval FMV testing?

Personalised recommendations for amino acids, fatty acids, vitamins, minerals, digestive support, and other nutrients are provided for each patient. Additionally, exposure to select toxic substances and oxidative stressors may need to be addressed. Comprehensive stool testing or SIBO breath testing may be appropriate to investigate the possible cause for maldigestion/malabsorption and dysbiosis.


  1. WHO. Malnutrition. Fact sheets 2018; Accessed April 15, 2019.
  2. Su KP, Matsuoka Y, Pae CU. Omega-3 Polyunsaturated Fatty Acids in Prevention of Mood and Anxiety Disorders. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. 2015;13(2):129-137.
  3. Grosso G, Galvano F, Marventano S, et al. Omega-3 fatty acids and depression: scientific evidence and biological mechanisms. Oxidative medicine and cellular longevity. 2014;2014:313570.
  4. Smith MA, Beilin LJ, Mori TA, Oddy WH. Essential fatty acids and mood: a systematic review of observational studies. Translational psychiatry. 2018;8(1):192.
  5. Zheng P, Chen JJ, Huang T, et al. A novel urinary metabolite signature for diagnosing major depressive disorder. Journal of proteome research. 2013;12(12):5904-5911.
  6. Wijendran V, Hayes KC. Dietary n-6 and n-3 fatty acid balance and cardiovascular health. Annual review of nutrition. 2004;24:597-615
  7. Shimizu M, Miyazaki T, Takagi A, et al. Low circulating coenzyme Q10 during acute phase is associated with inflammation, malnutrition, and in-hospital mortality in patients admitted to the coronary care unit. Heart and vessels. 2017;32(6):668-673.
  8. Giesbertz P, Daniel H. Branched-chain amino acids as biomarkers in diabetes. Current opinion in clinical nutrition and metabolic care. 2016;19(1):48-54.
  9. Adams SH. Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state. Advances in nutrition (Bethesda, Md). 2011;2(6):445-456.
  10. Durá-Travé T, Gallinas-Victoriano F, Cortes-Castell E, Moya-Benavent M. Amino Acid Plasma Concentrations and Urinary Excretion in Young Diabetics. In: Diabetes and Its Complications. IntechOpen; 2017.
  11. Simopoulos AP. An Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases the Risk for Obesity. Nutrients. 2016;8(3):128.
  12. Liu A, Zhou W, Qu L, et al. Altered Urinary Amino Acids in Children With Autism Spectrum Disorders. Frontiers in cellular neuroscience. 2019;13:7.
  13. Li C, Shen K, Chu L, Liu P, Song Y, Kang X. Decreased levels of urinary free amino acids in children with autism spectrum disorder. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 2018;54:45-49.
  14. Kaluzna-Czaplinska J, Jozwik-Pruska J, Chirumbolo S, Bjorklund G. Tryptophan status in autism spectrum disorder and the influence of supplementation on its level. Metabolic brain disease. 2017;32(5):1585-1593.
  15. Kaluzna-Czaplinska J. Noninvasive urinary organic acids test to assess biochemical and nutritional individuality in autistic children. Clinical biochemistry. 2011;44(8-9):686-691.
  16. Dunstan RH, Sparkes DL, Macdonald MM, et al. Diverse characteristics of the urinary excretion of amino acids in humans and the use of amino acid supplementation to reduce fatigue and sub-health in adults. Nutrition journal. 2017;16(1):19.
  17. Hugh Dunstan R, Sparkes DL, Macdonald MM, et al. Altered amino acid homeostasis and the development of fatigue by breast cancer radiotherapy patients: A pilot study. Clinical biochemistry. 2011;44(2-3):208-215.
  18. Niblett SH, King KE, Dunstan RH, et al. Hematologic and urinary excretion anomalies in patients with chronic fatigue syndrome. Experimental biology and medicine (Maywood, NJ). 2007;232(8):1041-1049.
  19. Nozaki S, Tanaka M, Mizuno K, et al. Mental and physical fatigue-related biochemical alterations. Nutrition (Burbank, Los Angeles County, Calif). 2009;25(1):51-57.
  20. Reddell L, Cotton BA. Antioxidants and micronutrient supplementation in trauma patients. Current opinion in clinical nutrition and metabolic care. 2012;15(2):181-187.
  21. Broer S, Broer A. Amino acid homeostasis and signalling in mammalian cells and organisms. The Biochemical journal. 2017;474(12):1935-1963.
  22. Duranton F, Lundin U, Gayrard N, et al. Plasma and urinary amino acid metabolomic profiling in patients with different levels of kidney function. Clinical journal of the American Society of Nephrology : CJASN. 2014;9(1):37-45.
Analyte List
2-Hydroxyphenylacetic Acid
3-Hydroxyisovaleric Acid
3-Hydroxyphenylacetic Acid
3-Hydroxyproprionic Acid
4-Hydroxyphenylacetic Acid
5-OH-Indoleacetic Acid
8-hydroxy-deoxy Guanosine (8-OHdG)
Adipic Acid
Alpha-amino-N-butyric acid
Alpha-aminoadipic acid
Anserine (dipeptide)
Aspartic acid
Benzoic Acid
Beta-aminoisobutyric acid
Carnosine (dipeptide)
Cis-Aconitic Acid
Citramalic Acid
Citric Acid
Coenzyme Q 10
Dihydroxyphenylpropionic Acid
Formiminoglutamic Acid
Gamma-aminobutyric acid
Glutamic acid
Glutaric Acid
Hippuric Acid
Homogentisic Acid
Homovanillic Acid
Indoleacetic Acid
Isocitric Acid
Kynurenic / Quinolinic Ratio
Kynurenic Acid
Lactic Acid
Lipid peroxides - urine
Malic Acid
Methylmalonic Acid
Orotic Acid
Phenylacetic Acid
Pyroglutamic Acid
Pyruvic Acid
Quinolinic Acid
Suberic Acid
Succinic Acid
Tartaric Acid
Vanilmandelic Acid
Vitamin D
Xanthurenic Acid
a-Hydroxyisobutyric Acid
a-Keto-b-Methylvaleric Acid
a-Ketoadipic Acid
a-Ketoglutaric Acid
a-Ketoisocaproic Acid
a-Ketoisovaleric Acid
a-Ketophenylacetic Acid
b-OH-Butyric Acid
b-OH-b-Methylglutaric Acid
Specimen Requirements
Urine and blood specimens required. Refer to clinician instructions for details